Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126571451 | 12657145 | 1 | I | 20160808 | 20160816 | 20160816 | EXP | PHHY2016BR110043 | NOVARTIS | 0.00 | F | Y | 52.00000 | KG | 20160816 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126571451 | 12657145 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, Q12MO | 21817 | 5 | MG | SOLUTION FOR INJECTION | |||||||
| 126571451 | 12657145 | 2 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | 21817 | SOLUTION FOR INJECTION | |||||||||||
| 126571451 | 12657145 | 3 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | 21817 | SOLUTION FOR INJECTION | |||||||||||
| 126571451 | 12657145 | 4 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | 21817 | SOLUTION FOR INJECTION | |||||||||||
| 126571451 | 12657145 | 5 | SS | ANADOR//METAMIZOLE | METAMIZOLE | 1 | Oral | 2 DF, QD (USED FOR 2 YEARS) | Y | 0 | 2 | DF | TABLET | QD | |||||
| 126571451 | 12657145 | 6 | SS | ANADOR//METAMIZOLE | METAMIZOLE | 1 | Y | 0 | TABLET | ||||||||||
| 126571451 | 12657145 | 7 | SS | ANADOR//METAMIZOLE | METAMIZOLE | 1 | Y | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126571451 | 12657145 | 1 | Osteoarthritis |
| 126571451 | 12657145 | 2 | Osteoporosis |
| 126571451 | 12657145 | 3 | Panic disorder |
| 126571451 | 12657145 | 4 | Spinal cord herniation |
| 126571451 | 12657145 | 5 | Viral infection |
| 126571451 | 12657145 | 6 | Nasopharyngitis |
| 126571451 | 12657145 | 7 | Headache |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126571451 | 12657145 | OT |
| 126571451 | 12657145 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126571451 | 12657145 | Condition aggravated | |
| 126571451 | 12657145 | Crying | |
| 126571451 | 12657145 | Gait disturbance | |
| 126571451 | 12657145 | Headache | |
| 126571451 | 12657145 | Influenza | |
| 126571451 | 12657145 | Malaise | |
| 126571451 | 12657145 | Memory impairment | |
| 126571451 | 12657145 | Nasopharyngitis | |
| 126571451 | 12657145 | Osteoarthritis | |
| 126571451 | 12657145 | Osteoporosis | |
| 126571451 | 12657145 | Poisoning | |
| 126571451 | 12657145 | Pyrexia | |
| 126571451 | 12657145 | Spinal cord herniation | |
| 126571451 | 12657145 | Spinal pain | |
| 126571451 | 12657145 | Viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |